keyword
https://read.qxmd.com/read/38695074/kidney-collecting-duct-derived-vasopressin-is-not-essential-for-appropriate-concentration-or-dilution-of-urine
#1
JOURNAL ARTICLE
Yvonne Zuchowski, Joshua Carty, Jonathan B Trapani, Jason Watts, Fabian Bock, Mingzhi Zhang, Andrew Terker, Roy Zent, Eric Delpire, Raymond C Harris, Juan Pablo Arroyo
We previously showed that kidney collecting ducts make vasopressin. However, the physiologic role of collecting-duct-derived vasopressin is uncertain. We hypothesized that collecting-duct-derived vasopressin was required for appropriate concentration of urine. We developed a vasopressin conditional knockout mouse model wherein Cre recombinase expression induces deletion of Avp exon 1 in the distal nephron. We then used age-matched 8 - 12 week old Avp fl/fl; Ksp -Cre(-) (WT) and Avp fl/fl; Ksp -Cre(+) mice for all experiments...
May 2, 2024: American Journal of Physiology. Renal Physiology
https://read.qxmd.com/read/38693275/arginine-vasopressin-deficiency-diagnosis-management-and-the-relevance-of-oxytocin-deficiency
#2
REVIEW
Cihan Atila, Julie Refardt, Mirjam Christ-Crain
Polyuria-polydipsia syndrome can be caused by central diabetes insipidus, nephrogenic diabetes insipidus or primary polydipsia. To avoid confusion with diabetes mellitus, the name 'central diabetes insipidus' was changed in 2022 to arginine vasopressin (AVP) deficiency and 'nephrogenic diabetes insipidus' was renamed as AVP resistance. To differentiate the three entities, various osmotic and non-osmotic copeptin-based stimulation tests have been introduced in the past decade. The hypertonic saline test plus plasma copeptin measurement emerged as the test with highest diagnostic accuracy, replacing the water deprivation test as the gold standard in differential diagnosis of the polyuria-polydipsia syndrome...
May 1, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38660455/tachyphylaxis-and-reproducibility-of-desmopressin-response-in-perioperative-persons-with-nonsevere-hemophilia-a-implications-for-clinical-practice
#3
JOURNAL ARTICLE
L G R Romano, L M Schütte, R M van Hest, K Meijer, B A P Laros-van Gorkom, L Nieuwenhuizen, J Eikenboom, F C J I Heubel-Moenen, N Uitslager, M Coppens, K Fijnvandraat, M H E Driessens, S Polinder, M H Cnossen, F W G Leebeek, R A A Mathôt, M J H A Kruip
BACKGROUND: Desmopressin is frequently used perioperatively in persons with nonsevere hemophilia A. However, increase in factor (F)VIII:C after desmopressin use is interindividually highly variable. Tachyphylaxis has only been reported in test setting for persons with hemophilia A, with a remaining response of approximately 70% after a second dose compared with that after a first dose. OBJECTIVES: To study tachyphylaxis of FVIII:C response after multiple administration(s) of desmopressin in perioperative persons with nonsevere hemophilia A...
March 2024: Research and Practice in Thrombosis and Haemostasis
https://read.qxmd.com/read/38658606/a-camp-biosensor-based-assay-for-measuring-plasma-arginine-vasopressin-levels
#4
JOURNAL ARTICLE
Kosuke Doi, Kouki Kawakami, Tatsuya Ikuta, Asuka Inoue
Arginine-vasopressin (AVP), a cyclic peptide hormone composed of nine amino acids, regulates water reabsorption by increasing intracellular cyclic adenosine monophosphate (cAMP) concentrations via the vasopressin V2 receptor (V2R). Plasma AVP is a valuable biomarker for the diagnosis of central diabetes insipidus (CDI) and is commonly measured using radioimmunoassay (RIA). However, RIA has several drawbacks, including a long hands-on time, complex procedures, and handling of radioisotopes with special equipment and facilities...
April 24, 2024: Scientific Reports
https://read.qxmd.com/read/38643357/successful-treatment-of-lithium-induced-nephrogenic-diabetes-insipidus-with-celecoxib-a-promising-therapeutic-option
#5
JOURNAL ARTICLE
Ryunosuke Hashikawa, Hiroyuki Yamada, Toshihito Fujii, Shigeru Ohtsuru
BACKGROUND Nephrogenic diabetic insipidus (NDI) poses a challenge in clinical management, particularly when associated with lithium ingestion. Non-selective non-steroidal anti-inflammatory drugs (NSAIDs) have been widely used for the treatment of numerous diseases worldwide, including NDI. However, many studies have reported the diverse adverse effects of long-term use of non-selective NSAIDs. Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is a better drug to relieve pain and inflammation in terms of long-term safety and efficacy than non-selective NSAIDs...
April 21, 2024: American Journal of Case Reports
https://read.qxmd.com/read/38634131/cannabinoid-receptor-type-1-activation-causes-a-water-diuresis-by-inducing-an-acute-central-diabetes-insipidus-in-mice
#6
JOURNAL ARTICLE
Joshua L Rein, Ken Mackie, Thomas R Kleyman, Lisa M Satlin
Cannabis and synthetic cannabinoid consumption is increasing worldwide. Cannabis contains numerous phytocannabinoids that act on the G-protein-coupled cannabinoid receptors type 1 (CB1R) and type 2 (CB2R) expressed throughout the body, including the kidney. Essentially every organ, including the kidney, produces endocannabinoids (ECs), endogenous ligands to these receptors. Cannabinoids acutely increase urine output in rodents and humans, thus potentially influencing total-body water and electrolyte homeostasis...
April 18, 2024: American Journal of Physiology. Renal Physiology
https://read.qxmd.com/read/38616722/long-term-safety-of-desmopressin-orally-disintegrating-tablets-in-men-with-nocturia-due-to-nocturnal-polyuria-interim-results-of-a-specified-drug-use-results-survey-in-japan
#7
JOURNAL ARTICLE
Yoshimasa Ogawa, Shujiro Murata, Kiyotoshi Kuramoto, Atsushi Nakano
OBJECTIVES: This interim report presents the 12-week results of a post-marketing surveillance evaluating the safety of desmopressin orally disintegrating tablets 25 and 50 μg in Japanese men with nocturia due to nocturnal polyuria. METHODS: Of the planned study population of 1000 Japanese men receiving desmopressin for the first time for nocturia due to nocturnal polyuria, 971 cases were enrolled. In this interim analysis, 9 cases, including 6 registry violations and 3 cases of unconfirmed desmopressin dosing, were excluded from the 354 case report forms collected and fixed by the end of December 2021, and data up to 12 weeks after administration in 345 cases were defined as the safety analysis set...
May 2024: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/38614785/valproate-induced-hyperammonemic-encephalopathy-treated-by-l-ornithine-l-aspartate-a-case-report
#8
Yan Yu-E, Liu Zhi-Qin, Lei Hui, Di Zheng-Li, Zhang Fang, Yong Fang
A 63-year-old man developed reduced consciousness and dysphagia progressively. Examination and parameters were normal, except for a Glasgow Coma Scale score of seven, and his grading on the swallow water test increased from grade 1 to grade 5. Brain imaging and blood tests were unexplainable except by high plasma ammonia. His past medical history included cerebral infarction, hypertension and epilepsy induced by cerebral hyperperfusion syndrome. He was rceiving antiepileptic treatment of continuously intravenously pumped sodium valproate of 64 mg/h for 4 days, which overlapped for 12 hours with taking 500 mg sustained release tablets...
May 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38609171/personalized-non-invasive-diagnostic-algorithms-based-on-urinary-free-cortisol-in-acth-dependant-cushing-s-syndrome
#9
JOURNAL ARTICLE
Julie Lavoillotte, Kamel Mohammedi, Sylvie Salenave, Raluca Maria Furnica, Dominique Maiter, Philippe Chanson, Jacques Young, Antoine Tabarin
CONTEXT: Current guidelines for distinguishing Cushing's disease (CD) from ectopic ACTH secretion (EAS) are questionable, as they use pituitary MRI as first-line investigation for all patients, CRH testing is no longer available and they suggest performing inferior petrosal sinus sampling (BIPPS), an invasive and rarely available investigation, in many patients. OBJECTIVE: To establish non-invasive personalized diagnostic strategies based on the probability of EAS estimated from simple baseline parameters...
April 13, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38606956/bilateral-inferior-petrosal-sinus-sampling-in-the-differential-diagnosis-of-acth-dependent-cushing-s-syndrome-a-reappraisal
#10
REVIEW
Majid Valizadeh, Behnaz Abiri, Farhad Hosseinpanah, Ashley Grossman
Cushing's syndrome (CS) is a rare disorder, once exogenous causes have been excluded. However, when diagnosed, the majority of cases are adrenocorticotropic hormone (ACTH)-dependent, of which a substantial minority are due to a source outside of the pituitary, ectopic ACTH syndrome (EAS). Differentiating among pituitary-dependent CS, Cushing's disease (CD) and an ectopic source can be problematic. Because non-invasive tests in the evaluation of CS patients often lack adequate sensitivity and specificity, bilateral inferior petrosal sinus sampling (BIPSS), a minimally invasive procedure performed during the investigation of ACTH-dependent CS, can be extremely helpful...
April 12, 2024: Journal of Internal Medicine
https://read.qxmd.com/read/38606623/electroencephalography-based-investigation-of-the-effects-of-oral-desmopressin-on-improving-slow-wave-sleep-time-in-nocturnal-polyuria-patients-the-distinct-study-a-single-arm-open-label-single-assignment-trial
#11
JOURNAL ARTICLE
Kazumasa Torimoto, Daisuke Gotoh, Yasushi Nakai, Makito Miyake, Kiyohide Fujimoto
AIMS: To investigate changes in subjective and objective sleep quality after desmopressin administration in patients with nocturia due to nocturnal polyuria (NP) using electroencephalography (EEG) and the Pittsburgh sleep quality index (PSQI). METHODS: Twenty male patients (≥65 years old) with NP participated in this study. The inclusion criteria were nocturnal frequency ≥ 2, NP index (NPi) ≥ 0.33, first uninterrupted sleep period (FUSP) ≤ 2...
April 12, 2024: Neurourology and Urodynamics
https://read.qxmd.com/read/38595335/factor-viii-and-von-willebrand-factor-are-wavering-proteins-the-basis-for-the-therapeutic-development-of-desmopressin
#12
JOURNAL ARTICLE
Pier Mannuccio Mannucci, Simona Maria Siboni
No abstract text is available yet for this article.
February 2024: Research and Practice in Thrombosis and Haemostasis
https://read.qxmd.com/read/38594156/methodologic-quality-and-pharmacotherapy-recommendations-for-patient-blood-management-guidelines-for-cardiac-surgery-on-cardiopulmonary-bypass
#13
REVIEW
Xiaojing Huang, Pengqiang Du, Haipan Jia, Aifeng Wang, Ying Hua, Xuelan Liu, Kaiyuan Wu, Bin Li, Hongwei Zhao
Patient blood management (PBM) guidelines for patients undergoing cardiac surgery under cardiopulmonary bypass (CPB) have increased during the past decade, and pharmacotherapy plays an important role in PBM. In the face of the undefined consistency in the methodologic quality and pharmacotherapy recommendations across multiple guidelines, this study exclusively evaluated methodologies of the related guideline development process, and compiled medication recommendations of PBM for cardiac surgery patients. PBM guidelines for cardiac surgery under CPB were searched through some mainstream literature and guideline databases from database establishment to May 15, 2023...
March 12, 2024: Journal of Cardiothoracic and Vascular Anesthesia
https://read.qxmd.com/read/38589989/an-algorithm-for-control-of-excessive-perioperative-bleeding-and-ecchymosis-in-rhinoplasty-patients-based-on-4-decades-of-experience
#14
JOURNAL ARTICLE
Bahman Guyuron, Cagri Cakmakoglu, Vardhan Avasarala
BACKGROUND: Persistent intraoperative bleeding, excessive post-operative ecchymosis, epistaxis, or blood collection in the supratip area increases the complexity of rhinoplasty, causing suboptimal outcomes. We present an intraoperative bleeding management algorithm developed by the senior author (B.G.) based on 43 years of experience and assess its efficacy in achieving hemostatic control through 103 consecutive cases. METHODS: A retrospective chart review was conducted on 103 consecutive patients who had undergone septorhinoplasty by a single surgeon...
April 9, 2024: Plastic and Reconstructive Surgery
https://read.qxmd.com/read/38566339/thiazide-associated-hyponatremia-in-arterial-hypertension-patients-a-nationwide-population-based-cohort-study
#15
JOURNAL ARTICLE
Soie Kwon, Hasung Kim, Jungkuk Lee, Jungho Shin, Su Hyun Kim, Jin Ho Hwang
OBJECTIVE: Thiazides are the first-line treatment for hypertension, however, they have been associated with hospitalizations for thiazide-associated hyponatremia (TAH). The aim of this study was to evaluate the risk of TAH and other drug-associated hyponatremia in a Korean population. METHODS: The study used big data from the National Health Insurance Sharing Service of 1,943,345 adults treated for hypertension from January 2014 to December 2016. The participants were divided into two groups based on the use of thiazides...
April 2, 2024: Journal of Evidence-based Medicine
https://read.qxmd.com/read/38565838/the-diagnostic-yield-of-inferior-petrosal-sinus-sampling-in-cushing-syndrome-in-the-era-of-ovine-crh-shortage
#16
JOURNAL ARTICLE
Lukas Andereggen, Jan Gralla, Emanuel Christ
PURPOSE: The ovine corticotropin-releasing hormone (oCRH) stimulation test has been routinely used in the diagnostic work-up of ACTH-dependent Cushing syndrome (CS). With oCRH currently being out-of-stock in Europe, we aimed at evaluating the diagnostic performance of inferior petrosal sinus sampling (IPSS) without oCRH stimulation. METHODS: We compared the values of 40 patients with ACTH-dependent CS and negative MRI findings in whom ACTH was measured before and after oCRH stimulation...
April 3, 2024: Acta Neurochirurgica
https://read.qxmd.com/read/38553491/safety-and-efficacy-of-proactive-versus-reactive-administration-of-desmopressin-in-severe-symptomatic-hyponatremia-a-randomized-controlled-trial
#17
RANDOMIZED CONTROLLED TRIAL
Kamolwan Pakchotanon, Nichanone Kanjanasuphak, Anan Chuasuwan, Pongsathorn Gojaseni, Anutra Chittinandana
This randomized controlled trial aimed to evaluate the safety and efficacy of proactive versus reactive desmopressin (DDAVP) strategies in treating severe symptomatic hyponatremia. Conducted from June 20, 2022, to February 20, 2023, it involved 49 patients with serum sodium levels below 125 mmol/L. Patients were assigned to either the proactive group, receiving DDAVP immediately upon diagnosis, or the reactive group, receiving DDAVP only if the serum sodium level tended to be overcorrected. The primary outcome was the incidence of overcorrection...
March 29, 2024: Scientific Reports
https://read.qxmd.com/read/38545460/patient-and-caregiver-perspectives-of-fluid-discharge-protocols-following-pituitary-surgery
#18
JOURNAL ARTICLE
Julia J Chang, Alexis Amano, Cati Brown-Johnson, Olivia Chu, Victoria Gates-Bazarbay, Erin Wipff, Samantha M R Kling, Mohamed Alhadha, Juan Carlos Fernandez-Miranda, Stacie Vilendrer
BACKGROUND: Post-operative fluid restriction after transsphenoidal surgery (TSS) for pituitary tumors may effectively prevent delayed hyponatremia, the most common cause of readmission. However, implementation of individualized fluid restriction interventions after discharge is often complex and poses challenges for provider and patient. The purpose of this study was to understand the factors necessary for successful implementation of fluid restriction and discharge care protocols following TSS...
March 2024: Journal of Clinical & Translational Endocrinology
https://read.qxmd.com/read/38521738/differential-regulation-of-human-thrombospondin-1-upon-systemic-desmopressin-versus-endotoxin-challenge
#19
JOURNAL ARTICLE
Andreas Scheuba, Branislav Zagrapan, Luca Martelanz, Vanessa Eder, Nahla Ibrahim, Sonja Bleichert, Viktoria Knöbl, Hubert Hayden, Sarah von Kuenheim, Katharina Münch, Nina Buchtele, Christian Schoergenhofer, Katarina D Kovacevic, Edith Lackner, Christa Drucker, Christoph Neumayer, Bernd Jilma, Christine Brostjan
No abstract text is available yet for this article.
January 15, 2024: Thrombosis Research
https://read.qxmd.com/read/38518896/standardisation-of-definition-and-management-for-bleeding-disorder-of-unknown-cause-communication-from-the-ssc-of-the-isth
#20
Ross I Baker, Philip Choi, Nicola Curry, Johanna Gebhart, Keith Gomez, Yvonne Henskens, Floor Heubel-Moenen, Paula James, Rezan Abdul Kadir, Peter Kouides, Michelle Lavin, Marie Lordkipanidze, Gillian Lowe, Andrew Mumford, Nicola Mutch, Michael Nagler, Maha Othman, Ingrid Pabinger, Robert Sidonio, Will Thomas, James S O'Donnell
In many patients referred with significant bleeding phenotype, laboratory testing fails to define any hemostatic abnormalities. Clinical practise with respect to diagnosis and management of this patient cohort poses significant clinical challenges. We recommend that bleeding history in these patients should be objectively assessed using the ISTH bleeding assessment tool (BAT). Patients with increased BAT scores should progress to hemostasis laboratory testing. To diagnose BDUC, normal complete blood count, prothrombin time, activated partial thromboplastin time, thrombin time, von Willebrand factor antigen, von Willebrand factor function; coagulation factors VIII, IX and XI and platelet light transmission aggregometry (LTA) should be the minimum laboratory assessment...
March 20, 2024: Journal of Thrombosis and Haemostasis: JTH
keyword
keyword
90039
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.